84.5%
haematological malignanciesPEG-Aspblinatumomab
…vidence-based management guidelines exist, especially regarding haematological malignancies and haematopoietic stem cell transplantion (HSCT). This case hi…
25articles mentioning diseases
47disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Haematological malignancies ×
Haematological malignancies
This disease is selected. Its supporting articles are shown below.
Articles mentioning Haematological malignancies
25 articles · page 2 of 3haematological malignanciesrefractory diffuse large B-cell lymphomavoriconazolechimeric antigen receptor T-cell therapyazole
…e in profoundly immunosuppressed hosts, particularly those with haematological malignancies or receiving cellular therapies. Diagnosis is often challenging…
haematological malignanciesacute lymphoblastic or myeloblastic leukaemiaComité de Protection des Personnes Ile de France IICUintensive chemotherapy
…Introduction Patients with haematological malignancies undergoing intensive chemotherapy with or without haematopoieti…
non-small-cell lung cancerhaematological malignanciescolorectalbreastgarlicHPoreganochamomilepepperginger+4 more
…ancer types were colorectal (28; 25.0%), breast (26; 23.2%) and non-small-cell lung cancer (20; 17.9%).Overall, 104 (92.9%) patients reported HP use. 73 (…
haematological malignanciespaclitaxelcyclophosphamidedocetaxeldoxorubicincarboplatinbevacizumabtertiary hospitaloncological treatmentHP+1 more
…25) were included. Patients enrolled in clinical trials or with haematological malignancies were excluded. Socio-demographic data were collected from the e…
haematological malignanciessolid tumoursUK Association of Clinical Genomics SciencesSVIG-UKUK laboratoriesUK Somatic Variant Interpretation Group
…fied through genomic testing in patients with solid tumours and haematological malignancies. SVIG-UK scientists conducted a review of existing somatic vari…
haematological malignanciesImmune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)ICANSChimeric Antigen Receptor T-cell (CAR-T) therapyCAR-T therapy
…ptor T-cell (CAR-T) therapy has revolutionised the treatment of haematological malignancies. Despite its efficacy, CAR-T therapy is associated with a high …
solid cancerovarian cancerhaematological malignanciesManchester Cancer Research BiobankChimeric antigen receptor (CAR) T cell therapy
…gical malignancies but limited clinical benefit in treatment of solid cancer. Tumour antigen heterogeneity and antigen escape are obstacles …
haematological malignanciesmetastatic melanomaPeter MacCallum Cancer Centre
…us success of chimeric antigen receptor (CAR) T cell therapy in haematological malignancies has not been recapitulated in the solid tumour setting, owing t…
solid tumourshaematological malignanciessolid tumorsChimeric Antigen Receptor T (CAR-T) cell therapyEuropean Research CouncilERCanticancer drugsMinisterio de Educacion y Formacion ProfesionalHorizon 2020 research and innovation programmeICoMICS
…buting to the development of more effective immunotherapies for solid tumours.This work was supported by the European Research Council (ERC) …
transverse myelitishaematological malignanciesacute disseminated encephalomyelitiscranial neuropathiesGuillain-Barré syndromeGBSADEMMethylprednisoloneAnakinraBiTE therapy+1 more
…ature describes neurological toxicities beyond ICANS, including transverse myelitis, Guillain-Barré syndrome (GBS), acute disseminated encephalomye…
haematological malignanciesautoimmune neurological disordersICANSimmune effector cell-associated neurotoxicity syndrome (ICANS)ICANS-relatedChimeric antigen receptor T-cell (CAR-T) therapyThe Alfred Hospital
…cell (CAR-T) therapy has transformed the treatment landscape of haematological malignancies and is being trialled for autoimmune neurological disorders. Ho…